Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women.
about
Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease--a perspectiveTriglycerides as vascular risk factors: new epidemiologic insightsGenome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants.Genetic Loci associated with C-reactive protein levels and risk of coronary heart diseaseLow-density lipoprotein cholesterol, apolipoprotein B, and risk of coronary heart disease: from familial hyperlipidemia to genomicsClinical usefulness of novel serum and imaging biomarkers in risk stratification of patients with stable anginaClinical review: Screening for coronary artery disease in type 2 diabetes.Nonstatin Low-Density Lipoprotein-Lowering Therapy and Cardiovascular Risk Reduction-Statement From ATVB CouncilPolymorphism in the apolipoprotein(a) gene, plasma lipoprotein(a), cardiovascular disease, and low-dose aspirin therapyLipid-related markers and cardiovascular disease prediction.Implications of the obesity epidemic for lipid-lowering therapy: non-HDL cholesterol should replace LDL cholesterol as the primary therapeutic targetNovel lipoprotein subfraction and size measurements in prediction of mortality in maintenance hemodialysis patients.Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study.Lipids and carotid plaque in the Northern Manhattan Study (NOMAS)A salmon protein hydrolysate exerts lipid-independent anti-atherosclerotic activity in ApoE-deficient miceHDL anti-oxidant function associates with LDL level in young adults.Serum lipids, apolipoproteins, and mortality among coronary artery disease patientsNon-high-density lipoprotein fractions are strongly associated with the presence of metabolic syndrome independent of obesity and diabetes: a population-based study among Iranian adultsA randomized trial of transdermal and oral estrogen therapy in adolescent girls with hypogonadism.Biomarkers in peripheral arterial disease patients and near- and longer-term mortalityThe Challenges of Prevention, Diagnosis and Treatment of Ischemic Heart Disease in WomenSerum Non-High-Density Lipoprotein Cholesterol and Risk of Cardiovascular Disease in Community Dwellers with Chronic Kidney Disease: the Hisayama StudyPersonality and inflammation: the protective effect of openness to experience.The effect of almonds on anthropometric measurements and lipid profile in overweight and obese females in a weight reduction program: A randomized controlled clinical trial.High-sensitivity C-reactive protein predicts cardiovascular risk in diabetic and nondiabetic patients: effects of insulin-sensitizing treatment with pioglitazoneEffects of poly-bioactive compounds on lipid profile and body weight in a moderately hypercholesterolemic population with low cardiovascular disease risk: a multicenter randomized trialAssociation of the low-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio and concentrations of plasma lipids with high-density lipoprotein subclass distribution in the Chinese population.Higher high-density lipoprotein cholesterol in African-American women with polycystic ovary syndrome compared with Caucasian counterpartsIs the association between optimistic cardiovascular risk perceptions and lower rates of cardiovascular disease mortality explained by biomarkers of systemic inflammation or endothelial function? A case-cohort study.The relationship between high density lipoprotein subclass profile and plasma lipids concentrationsOral postmenopausal hormone therapy, C-reactive protein, and cardiovascular outcomes.Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial.Should statin therapy be allocated on the basis of global risk or on the basis of randomized trial evidence?Consumption of less than 10% of total energy from added sugars is associated with increasing HDL in females during adolescence: a longitudinal analysis.Total cholesterol and triglycerides are associated with the development of new bone marrow lesions in asymptomatic middle-aged women - a prospective cohort studyCombination of niacin extended-release and simvastatin results in a less atherogenic lipid profile than atorvastatin monotherapyNontraditional serum lipid variables and recurrent stroke risk.Prediction of risk factors for coronary heart disease using Framingham Risk Score in Korean men.Non-high density lipoprotein cholesterol versus low density lipoprotein cholesterol as a discriminating factor for myocardial infarctionEffects of genetic variants on lipid parameters and dyslipidemia in a Chinese population.
P2860
Q24594814-A42FAB3D-7126-4783-9DEB-0942DD1E213FQ24618902-5D34651A-DEDC-427E-A575-8650B92A398AQ24645076-9DF89B66-DD37-4252-ADA6-CC9436BD9567Q24649709-6AB008CC-06BF-49C1-8ADB-4D534FAC050BQ26853114-EA890890-21E7-4EA6-84A2-59BFCF4A0B69Q26859111-F958FE51-7B1E-450D-AD72-4E6C6704D3BBQ26860716-B2D0EEC7-B665-453C-86CA-4658B35BDD53Q28084156-30D59751-CAF6-4EA4-9FFB-0FC864D7C37AQ28293224-341332EB-CEEC-4026-B62E-A4CA739A26CFQ28654304-A735A1A1-EEED-41A6-B39E-72920C20D8C6Q30370672-F5DD5A3A-2084-4501-B05F-498656ED7FE1Q30423610-81DC33F1-7038-435B-9A48-7B46B2C69BB1Q31035233-76F88AEC-C188-49FC-B421-79AEEA3D3AEDQ33520363-89E9EC7D-E05D-4146-B7D8-5FD9F7801436Q33632677-1B1BA86C-EF83-4EE4-A422-2AC934BB0B40Q33689682-A9A83AE8-5811-4008-A4C4-099A938721A7Q33760061-793D28C0-5A85-423E-9182-C9A1ACCA3C18Q33776151-BFCE3C5D-9522-4F90-A0F5-000C45FE4B4AQ33820367-CBD651E6-F7CA-42ED-A2A3-23A7C9F014B0Q33828811-13EA28AA-C51E-4DF1-8A5B-A51A7F49F7FCQ33917513-A0FB5BD0-F4E2-4AF6-A899-577DD96356E6Q33918753-2A7D9C61-F4E2-4827-B605-2A21ECEDF14EQ33966450-11C13AC1-0239-4F19-8708-BB3B97C4B88AQ33977352-56DB4FE5-2A2D-46AA-BC08-C390CBEAFE56Q33979763-087A11F6-CDEA-432B-B735-9D7591ADA5C6Q33988933-C11A20B8-7E4A-4CBA-A320-F7F3BF6D4657Q34062910-B752AD9B-7B10-4281-9D7B-D8900FA01270Q34113140-DCF19484-3C35-498E-80E5-F7BECB3029F5Q34174057-1F4285DA-AEDB-424E-B5BE-4A0BE42C690BQ34267570-DD311490-96CF-4BD4-9300-8BA60CFC08D9Q34283107-AD7F41F1-75B3-4D83-8184-C38E00150E5BQ34293369-3097FB99-CF13-4096-9FBE-A290B1272E0CQ34360294-F47CBB91-A308-4C1B-80E7-6C185B2B0BC2Q34406999-B594461A-1046-43AA-81E2-2AAEAAC271EFQ34413298-ABDC642A-EF2E-4605-934E-A3861E52A2F9Q34417470-7CE80056-A548-4461-8C54-546A831E6631Q34423344-EBDB559B-CA0B-42CA-8A48-FDBA6FA6562AQ34427908-22040877-D4D9-4D87-95EB-CC385A9FC65AQ34480124-879FD620-1CFD-4443-905D-45ABE0239A61Q34503417-889D535A-74A3-4515-9F5F-E94D44C20748
P2860
Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Non-HDL cholesterol, apolipopr ...... rdiovascular disease in women.
@en
type
label
Non-HDL cholesterol, apolipopr ...... rdiovascular disease in women.
@en
prefLabel
Non-HDL cholesterol, apolipopr ...... rdiovascular disease in women.
@en
P2093
P356
P1476
Non-HDL cholesterol, apolipopr ...... rdiovascular disease in women.
@en
P2093
Gary Bradwin
Nancy R Cook
Paul M Ridker
P304
P356
10.1001/JAMA.294.3.326
P407
P577
2005-07-01T00:00:00Z